Matches in Nanopublications for { ?s ?p "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 34 of
34
with 100 items per page.
- assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP908613.RAtu5DdO2U31jKdPZ5G5hdbB1fCn5mWPntQ2s5-sWp1Q8130_assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP908613.RAtu5DdO2U31jKdPZ5G5hdbB1fCn5mWPntQ2s5-sWp1Q8130_provenance.
- NP919905.RAjmxKZc1v13WaDsI8otzxgdzL9Wup5nDU8A65FM5LHp8130_assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP919905.RAjmxKZc1v13WaDsI8otzxgdzL9Wup5nDU8A65FM5LHp8130_provenance.
- NP320204.RAjX543pwQL8KVqAlzvcMokW2ytcaN1Qkrd4KlQyq11C4130_assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP320204.RAjX543pwQL8KVqAlzvcMokW2ytcaN1Qkrd4KlQyq11C4130_provenance.
- NP676095.RAiqNdYH_RDXS53chRkScDyuc3SW1JYHyjnfGB_cGANQE130_assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP676095.RAiqNdYH_RDXS53chRkScDyuc3SW1JYHyjnfGB_cGANQE130_provenance.
- NP638143.RAoNCBdODJZnTfsvot2FLBFzxbO_tU20QTKGyt0fbmL1g130_assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP638143.RAoNCBdODJZnTfsvot2FLBFzxbO_tU20QTKGyt0fbmL1g130_provenance.
- NP630172.RAw4VdOcnl-Ilc_2svQZQsINJTEsyz5cUWDGCe3xX5Sog130_assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630172.RAw4VdOcnl-Ilc_2svQZQsINJTEsyz5cUWDGCe3xX5Sog130_provenance.
- NP411844.RA3huExHxjEx-Fw7ABQGLNMhJ6mzOFCCfLN8aZt1WwhKk130_assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411844.RA3huExHxjEx-Fw7ABQGLNMhJ6mzOFCCfLN8aZt1WwhKk130_provenance.
- NP624236.RAfnm-mfjOKNx8TmVCgtssxZhJrGDo32kxclH4H2TVCJY130_assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624236.RAfnm-mfjOKNx8TmVCgtssxZhJrGDo32kxclH4H2TVCJY130_provenance.
- NP631182.RAE3dh6846D1D0pwkvBOMvwYrCgKCYPSYTfhcgFrMc8Zw130_assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP631182.RAE3dh6846D1D0pwkvBOMvwYrCgKCYPSYTfhcgFrMc8Zw130_provenance.
- NP663962.RAKtL37DXmWzqnzP0VI0NqppcHt3xsVvRaOfl4bY9iBls130_assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP663962.RAKtL37DXmWzqnzP0VI0NqppcHt3xsVvRaOfl4bY9iBls130_provenance.
- assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP374730.RAbKV9fHDnkDkHQEqYZCqatOS23WjuKyIaMud_ESfQX2k130_assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP374730.RAbKV9fHDnkDkHQEqYZCqatOS23WjuKyIaMud_ESfQX2k130_provenance.
- NP374732.RAaNTQpnh5ADvu3THL9TRvuWl3rgRDuUh8qc9P_2DCzZM130_assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP374732.RAaNTQpnh5ADvu3THL9TRvuWl3rgRDuUh8qc9P_2DCzZM130_provenance.
- NP621671.RAB7QadAdrOLUWIrzMNodCh_aadRgsYJXD8GCP71czj_g130_assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621671.RAB7QadAdrOLUWIrzMNodCh_aadRgsYJXD8GCP71czj_g130_provenance.
- NP374733.RACEo2d42R0IPF3oBUWFVN5qGwNNX0Sd5r6EKek3HcG2Y130_assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP374733.RACEo2d42R0IPF3oBUWFVN5qGwNNX0Sd5r6EKek3HcG2Y130_provenance.
- NP622920.RAjzCrp60_bEa4F416aOCyWmQUXndAdHjDDjot_TWx5p0130_assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622920.RAjzCrp60_bEa4F416aOCyWmQUXndAdHjDDjot_TWx5p0130_provenance.
- NP374726.RAru1wuDI2_AsXBwu5t3QpxJ-80LwW6rw5o2oCqdaxu30130_assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP374726.RAru1wuDI2_AsXBwu5t3QpxJ-80LwW6rw5o2oCqdaxu30130_provenance.
- NP374728.RAuwqdoPRsSI_dozWooFQsKADxJplL_zvjlSSYwgyHVro130_assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP374728.RAuwqdoPRsSI_dozWooFQsKADxJplL_zvjlSSYwgyHVro130_provenance.
- NP374731.RAnLvFyFEezDzeuNkn_iABjwTn8VXsxnKGa3foVicWssE130_assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP374731.RAnLvFyFEezDzeuNkn_iABjwTn8VXsxnKGa3foVicWssE130_provenance.
- NP232541.RAyJRBJ5UBm11UJ90z3CqjN6l5ANULy48oJi49GfR8ZiQ130_assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232541.RAyJRBJ5UBm11UJ90z3CqjN6l5ANULy48oJi49GfR8ZiQ130_provenance.
- NP625376.RAG1djNtAKe6Otk6ROXa0AHrr2MVMOCpky31AITTLYZYU130_assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625376.RAG1djNtAKe6Otk6ROXa0AHrr2MVMOCpky31AITTLYZYU130_provenance.
- NP374729.RAHZ5l8fu3ZE8KKyn2q4q-i1aWSx0Lgw_1as49GAN6Ii4130_assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP374729.RAHZ5l8fu3ZE8KKyn2q4q-i1aWSx0Lgw_1as49GAN6Ii4130_provenance.
- NP374734.RAP1f9fmR4ehyvZ4O-EW6cOHycSaJLVJ47BRxfoPVO9DA130_assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP374734.RAP1f9fmR4ehyvZ4O-EW6cOHycSaJLVJ47BRxfoPVO9DA130_provenance.
- NP374725.RA7cisHtMG3AiT4nZ0u09eKMurVpZMiL_cRWravlvOKc0130_assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP374725.RA7cisHtMG3AiT4nZ0u09eKMurVpZMiL_cRWravlvOKc0130_provenance.
- NP374727.RA0OzgwYobg9VzJ-j7nhk9wx1zT5kavrT7IR_B38vRXyo130_assertion description "[Activation of PI3K/AKT survival pathway may contribute to the increased drug resistance in TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP374727.RA0OzgwYobg9VzJ-j7nhk9wx1zT5kavrT7IR_B38vRXyo130_provenance.